Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial

Epilepsy Research

Volumn 90, Issue 3, 2010, Pages 273-277

  Tonekaboni, S H ^a   Ghazavi, M ^b   Karimzadeh, P ^a   Mahvelati, F ^a   Ghofrani, M ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Add on; Childhood; Epilepsy; Levetiracetam; Refractory

Indexed keywords

BENZODIAZEPINE; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ANTICONVULSIVE AGENT; PIRACETAM;

ADD ON THERAPY; ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE DURATION; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; INFANT; MALE; MIXED SEIZURE; MORBIDITY; NEUROIMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; DRUG ADMINISTRATION; DRUG COMBINATION; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; INFANT; MALE; PIRACETAM; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77955056085     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2010.06.002     Document Type: Article

References (19)

1. Callenbach P.M.C., Arts W.F., ten Houten R., Augustijn P., Gunning W.B., Peeters E.A.J., Weber A.M., Stroink H., Geerts Y., Geerts A.T., Brouwer O.F. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Eur. J. Paediatric Neurol. 2008, 12:321-327.
2. Coppola G., Mangano S., Tortorella G., Pelliccia A., Fels A., Romano A., Nardello R., Habetswallner F., Licciardi F., Operto F.F., Pascotto A. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy. Epilepsy Res. 2004, 59:35-42.
3. Giroux P., Salas-Prato M., Théorêt Y., Carmant L. Levetiracetam use for refractory pediatric epileptic syndromes. Clin. Neurophysiol. 2007, 118:e187-e188.
4. Glauser T.A., Ayala R., Elterman R.D., Mitchell W.G., Van Orman C.B., Gauer L.J. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006, 66:1654.
5. Glauser T.A., Pellock J.M., Bebin E.M., Fountain N.B., Ritter F.J., Jensen C.M., Shields W.D. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial. Epilepsia 2002, 43:518-524.
6. Grosso S., Cordelli D.M., Franzoni E., Coppola G., Capovilla G., Zamponi N., Verrotti A., Morgese G., Balestri P. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy. Seizure 2007, 16:345-350.
7. Grosso S., Franzoni E., Coppola G., Iannetti P., Verrotti A., Cordelli D.M., Marchiani V., Pascotto A., Spalice A., Acampora B., Morgese G., Balestri P. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure 2005, 14:248-253.
8. Lagae L., Buyse G., Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial. Seizure 2005, 14:66-71.
9. Lagae L., Buyse G., Deconinck A., Ceulemans B. Effect of levetiracetam in refractory childhood epilepsy syndromes. Eur. J. Paediatric Neurol. 2003, 7:123-128.
10. Margineanu D.G., Matagne A., Kaminski R.M., Klitgaard H. Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in rats. Brain Res. Bull. 2008, 77:282-285.
11. Nakken K.O., Eriksson A.S., Lossius R.A.S.M., Johannessen S.I. A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy. Seizure 2003, 12:42-46.
12. Opp J., Tuxhorn I., May T., Kluger G., Wiemer-Kruel A., Kurlemann G., Gross-Selbeck G., Rating D., Brandl U., Bettendorf U., Härtel C., Korn-Merker E. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany. Seizure 2005, 14:476-484.
13. Peake D., Mordekar S., Gosalakkal J., Mukhtyar B., Buch S., Crane J., Wheway R., Rittey C., Donnelly J., Whitehouse W.P., Philip S. Retention rate of levetiracetam in children with intractable epilepsy at 1 year. Seizure 2007, 16:185-189.
14. Somerville E.R., McLaughlin D.B., Robinson M.K., Berkovic S.F. Adjunctive therapy of uncontrolled partial seizures with levetiracetam in Australian patients. Epilepsy Behav. 2007, 11:338-342.
15. Steinhoff B.J., Somerville E.R., Van Paesschen W., Ryvlin P., Schelstraete I. The SKATE(TM) study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy. Epilepsy Res. 2007, 76:6-14.
16. Tan M.J., Appleton R.E. Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience. Seizure 2004, 13:142-145.
17. Unalp A., Uran N., Ozsu E., zt rk A.A. ETP015 Add-on levetiracetam therapy in refractory childhood epilepsy: clinical experience in a child hospital. Eur. J. Paediatric Neurol. 2007, 11:85.
18. Wheless J.W., Ng Y.T. Levetiracetam in refractory pediatric epilepsy. J. Child Neurol. 2002, 17:413-415.
19. Wirrell E.C., Wood L., Hamiwka L.D., Sherman E.M.S. Parenting stress in mothers of children with intractable epilepsy. Epilepsy Behav. 2008, 13:169-173.